These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36737599)

  • 41. Regulation of ATG4B stability by RNF5 limits basal levels of autophagy and influences susceptibility to bacterial infection.
    Kuang E; Okumura CY; Sheffy-Levin S; Varsano T; Shu VC; Qi J; Niesman IR; Yang HJ; López-Otín C; Yang WY; Reed JC; Broday L; Nizet V; Ronai ZA
    PLoS Genet; 2012; 8(10):e1003007. PubMed ID: 23093945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.
    Khateb A; Deshpande A; Feng Y; Finlay D; Lee JS; Lazar I; Fabre B; Li Y; Fujita Y; Zhang T; Yin J; Pass I; Livneh I; Jeremias I; Burian C; Mason JR; Almog R; Horesh N; Ofran Y; Brown K; Vuori K; Jackson M; Ruppin E; Deshpande AJ; Ronai ZA
    Nat Commun; 2021 Sep; 12(1):5397. PubMed ID: 34518534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting of Ubiquitin E3 Ligase RNF5 as a Novel Therapeutic Strategy in Neuroectodermal Tumors.
    Principi E; Sondo E; Bianchi G; Ravera S; Morini M; Tomati V; Pastorino C; Zara F; Bruno C; Eva A; Pedemonte N; Raffaghello L
    Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural modeling of protein ensembles between E3 RING ligases and SARS-CoV-2: The role of zinc binding domains.
    Chasapis CT; Perlepes SP; Bjørklund G; Peana M
    J Trace Elem Med Biol; 2023 Jan; 75():127089. PubMed ID: 36209710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells.
    Wang G; Zhao Q; Zhang H; Liang F; Zhang C; Wang J; Chen Z; Wu R; Yu H; Sun B; Guo H; Feng R; Xu K; Zhou G
    Front Med; 2021 Apr; 15(2):252-263. PubMed ID: 33511555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correction To: The E3 ligase RNF5 restricts SARS-CoV-2 replication by targeting its envelope protein for degradation.
    Li Z; Hao P; Zhao Z; Gao W; Huan C; Li L; Chen X; Wang H; Jin N; Luo ZQ; Li C; Zhang W
    Signal Transduct Target Ther; 2023 Feb; 8(1):85. PubMed ID: 36849529
    [No Abstract]   [Full Text] [Related]  

  • 48. Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.
    Zhou Y; Zheng R; Liu S; Disoma C; Du A; Li S; Chen Z; Dong Z; Zhang Y; Li S; Liu P; Razzaq A; Chen X; Liao Y; Tao S; Liu Y; Xu L; Zhang Q; Peng J; Deng X; Li S; Jiang T; Xia Z
    J Biol Chem; 2022 Feb; 298(2):101584. PubMed ID: 35032548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acetylation Stabilizes Phosphoglycerate Dehydrogenase by Disrupting the Interaction of E3 Ligase RNF5 to Promote Breast Tumorigenesis.
    Wang C; Wan X; Yu T; Huang Z; Shen C; Qi Q; Xiang S; Chen X; Arbely E; Ling ZQ; Liu CY; Yu W
    Cell Rep; 2020 Aug; 32(6):108021. PubMed ID: 32783943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
    Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The human E3 ligase RNF185 is a regulator of the SARS-CoV-2 envelope protein.
    Zou C; Yoon H; Park PMC; Patten JJ; Pellman J; Carreiro J; Tsai JM; Li YD; Roy Burman SS; Donovan KA; Gasser J; Sperling AS; Nowak RP; Fischer ES; Davey RA; Ebert BL; Słabicki M
    iScience; 2023 May; 26(5):106601. PubMed ID: 37095859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination.
    Hu Y; Li W; Gao T; Cui Y; Jin Y; Li P; Ma Q; Liu X; Cao C
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insights into SARS-CoV-2: Medicinal Chemistry Approaches to Combat Its Structural and Functional Biology.
    Zhuo LS; Wang MS; Yang JF; Xu HC; Huang W; Shang LQ; Yang GF
    Top Curr Chem (Cham); 2021 Apr; 379(3):23. PubMed ID: 33886017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ring finger protein 5 activates sterol regulatory element-binding protein 2 (SREBP2) to promote cholesterol biosynthesis via inducing polyubiquitination of SREBP chaperone SCAP.
    Kuan YC; Takahashi Y; Maruyama T; Shimizu M; Yamauchi Y; Sato R
    J Biol Chem; 2020 Mar; 295(12):3918-3928. PubMed ID: 32054686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MARCH8 Targets Cytoplasmic Lysine Residues of Various Viral Envelope Glycoproteins.
    Zhang Y; Ozono S; Tada T; Tobiume M; Kameoka M; Kishigami S; Fujita H; Tokunaga K
    Microbiol Spectr; 2022 Feb; 10(1):e0061821. PubMed ID: 35019698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model.
    He ST; Qin H; Guan L; Liu K; Hong B; Zhang X; Lou F; Li M; Lin W; Chen Y; He C; Liu F; Lu S; Luo S; Zhu S; An X; Song L; Fan H; Tong Y
    J Med Virol; 2023 Jan; 95(1):e28281. PubMed ID: 36329614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.